Pharmaceutical Strategies Group is a firm that provides consulting services and investment management to nonprofit clients. They primarily provide their services regionally, with most clients in California, New Hampshire, and New York (although they are present in other states as well).
Most Pharmaceutical Strategies Group clients are health and welfare funds with revenues ranging from $255 million to $1.8 billion.
Previous legal names, trade names, or just variations of their name include: Pharmaceutical Strategies Group, LL; and Pharmaceutical Strategies Group LLC.
| Name | Type | Location | |
|---|---|---|---|
| 1 | 1199seiu National Benefit Fund for Health and Human Service Employees | 501(c)(9) | New York, NY |
| 2 | Northern New England Benefit Trust | 501(c)(9) | Manchester, NH |
| 3 | IBEW Local 332 Health Welfare Plan | 501(c)(9) | San Jose, CA |
Competitors to Pharmaceutical Strategies Group in the nonprofit sector include Mercer Investments, Sageview Advisory Group, TD Ameritrade Trust Company, Dimeo Schneider, Towers Watson Delaware Inc, Bank Of New York Mellon, Aon Hewitt, Sageview Advisory Group, LLC, Income Research and Management, and Cammack Larhette Advisors.
Log in to see a complete profile, including complete list of identified clients.
You're in good company! Cause IQ's customers include leading technology, accounting, financial services, consulting, fundraising, and other firms.
Our web-based information and tools help you grow, maintain, and serve your nonprofit clients.